This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ultragenyx Pharmaceutical Inc (RARE)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012
Cash and Equivalents 24.32M 7.43M 86.19M
Receivables 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 193.42M 55.23M 86.44M
Property, Plant & Equipment, Gross 4.51M 2.12M 1.72M
Accumulated Depreciation & Depletion 1.48M 797.00K 353.00K
Property, Plant & Equipment, Net 3.03M 1.32M 1.36M
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 1.52M 3.10M 509.00K
Total Non-Current Assets 4.55M 4.42M 1.87M
Liabilities & Shareholder Equity
Total Assets 197.97M 59.65M 88.32M
Accounts Payable 4.86M 1.44M 1.20M
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00
Total Current Liabilities 12.52M 5.92M 3.19M
Long Term Debt 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00
Other Non-Current Liabilities 505.00K 3.62M 788.00K
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 505.00K 128.55M 112.17M
Total Liabilities 13.02M 134.47M 115.36M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 184.94M -74.82M -27.05M
Common Par 32.00K 4.00K 3.00K
Additional Paid In Capital 324.13M 0.00 8.00K
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -139.04M -74.84M -27.06M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -174.00K 11.00K 0.00
Total Capitalization 184.94M -74.82M -27.05M
Total Equity 184.94M -74.82M -27.05M
Total Liabilities & Stock Equity 197.97M 59.65M 88.32M
Total Common Shares Outstanding 31.93M 29.06M 29.06M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 28.76M 3.38M 3.00M
Diluted Weighted Shares Outstanding 28.76M 3.38M 3.00M
Number of Employees 107 59 NA
Number of Part-Time Employees 0 0 NA

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RARE Ultragenyx Pharmaceutical Inc

Chart of RARE

Analysts Ratings for RARE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 1 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

RARE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs